Swiss Medical Equipment Stock News

SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis (SWX:NOVN) Stock Looks Reasonable Despite Its 89% Five Year Run

Novartis stock has delivered a strong 88.5% return over the past five years, and the valuation checks now point to a company that looks undervalued on market multiples but not as a straightforward bargain across every metric. Over the past 5 years, Novartis has returned 88.5%, which puts recent short term ups and downs into the context of a solid multi year share price performance. Protecting cash flows from key products such as Entresto, supported by the recent UK court win on its patent,...
SWX:SDZ
SWX:SDZPharmaceuticals

Did Sandoz’s Expanded Henlius Biosimilar Pact Just Redraw Its (SWX:SDZ) Investment Narrative?

Sandoz Group AG recently announced a collaboration agreement with Shanghai Henlius Biotech, Inc. to develop, manufacture and commercialise up to 10 biosimilars, including proposed versions of cetuximab, evolocumab and belimumab, with Henlius handling development and manufacturing and Sandoz holding commercial rights outside China under a milestones-based deal of up to US$322 million. This partnership lifts Sandoz’s biosimilar pipeline from 39 assets with potential to reach up to 46,...
SWX:ABBN
SWX:ABBNElectrical

Is ABB (SWX:ABBN) Fully Priced Following Its LevelTen Energy Deal?

Why ABB stock is drawing fresh attention after the LevelTen Energy deal ABB (SWX:ABBN) is back in focus after announcing a partnership and minority investment in LevelTen Energy, tying its electrification and energy management tools more tightly to global clean energy procurement. See our latest analysis for ABB. The LevelTen Energy announcement lands at a time when ABB's share price has gained clear momentum, with a 30 day share price return of 4.8% and a year to date share price return of...
SWX:SQN
SWX:SQNCapital Markets

Swissquote Stock And Other Trading Platforms Riding The Volatility Boom

With Michael Burry comparing the AI-fuelled rally to past bubbles and the CAPE ratio sitting close to its late 1999 peak, investors are watching a market where optimism and risk sit side by side. Trading venues and options infrastructure stocks can sit right in the slipstream of that activity. This article looks at three stocks exposed to the current news narrative and explains why their stories might deserve a place on your watchlist. The three stocks below are only a starting sample, and...
SWX:ALC
SWX:ALCMedical Equipment

Stronger Sales But Weaker Earnings Could Be A Game Changer For Alcon (SWX:ALC)

In the second quarter and first half of 2026, Alcon Inc. reported higher sales and revenue year on year, but net income for the six-month period fell to US$189 million from US$526 million, with basic and diluted earnings per share from continuing operations both dropping to US$0.39 from US$1.06. Even as Alcon maintained its full-year 2026 net sales growth guidance of 5% to 7%, the combination of rising revenue, lower profitability, and mixed valuation signals has sharpened investor focus on...
SWX:DOKA
SWX:DOKABuilding

3 Security Stocks Worth Watching As Demand For Better Protection Grows

Rising reports of violent homejackings around Lake Geneva are testing Switzerland’s image as a safe harbour for wealth, and that shift is drawing fresh attention to security and surveillance technology providers. When reputations and high end assets feel exposed, demand for better protection often moves quickly. This article walks through three stocks tied to these security themes and explains how the recent news could matter for their long term story. The stocks covered below are just a...
SWX:SCMN
SWX:SCMNTelecom

What Is Drawing Fresh Attention To Swisscom (SWX:SCMN)?

How Swisscom’s latest earnings update is shaping investor focus Swisscom (SWX:SCMN) drew fresh attention on 6 August 2026 after reporting half year results that combined lower sales of CHF 7,221 million with higher net income of CHF 669 million and basic EPS of CHF 12.92. See our latest analysis for Swisscom. Since the start of the year Swisscom’s share price has gained 10.36%, while the stock is down 5.47% over the past 90 days, and the 1 year total shareholder return of 14.85% points to...
SWX:GALD
SWX:GALDPharmaceuticals

Galderma Group (SWX:GALD) Wins EU Nod For Restylane Shaype, Is It Fully Priced?

Restylane Shaype launch puts Galderma Group in focus Galderma Group (SWX:GALD) has drawn fresh investor attention after securing European Union approval for Restylane Shaype, a hyaluronic acid gel designed specifically for minimally invasive chin shaping and augmentation. See our latest analysis for Galderma Group. The Restylane Shaype approval lands at a time when Galderma Group’s share price has eased in the very short term, with the 1 day and 7 day share price returns declining 3.11% and...
SWX:SREN
SWX:SRENInsurance

Swiss Re (SWX:SREN), Why Is Its Latest Update Drawing Attention?

Swiss Re (SWX:SREN) is drawing fresh attention after its H1 2026 results, with net income of US$2.831b and basic earnings per share of US$9.57 for the six months to June 30. See our latest analysis for Swiss Re. Swiss Re's share price has climbed over the past quarter, with a 90 day share price return of 14.82% and a year to date share price return of 7.15%. The 3 year total shareholder return of 93.41% highlights how long term holders have been rewarded, as recent earnings keep interest in...
SWX:KOMN
SWX:KOMNMachinery

Komax Holding (SWX:KOMN) Stock Price Trails Losses Despite Deep Value Gap

Komax Holding shares closed at CHF78.70 on Friday, only modestly higher over the past week and month, which suggests investors came into these results cautiously optimistic but not euphoric. The earnings headline is simple and uncomfortable. The wiring automation specialist is still loss making, with a basic earnings per share loss of CHF0.96 in the first half and trailing twelve month losses that remain in the mid single digit millions of francs. The key issue now is valuation. The stock...
SWX:ALC
SWX:ALCMedical Equipment

Is Alcon (SWX:ALC) Below Fair Value On Mixed Earnings And RxSight News?

Alcon (SWX:ALC) is back in focus after its second quarter 2026 earnings report. The results showed higher sales and revenue but a much lower net income figure, giving investors mixed signals to digest. See our latest analysis for Alcon. The recent earnings announcement, maintained 2026 net sales growth guidance, and the RxSight collaboration have come alongside a 90 day share price return of 17.97%, although the 1 year total shareholder return is down 13.93%. If this mix of earnings and...
SWX:ARYN
SWX:ARYNFood

ARYZTA (SWX:ARYN) Just Gave Investors Something To Reassess

ARYZTA (SWX:ARYN) has come into focus after reporting half year 2026 results that showed slightly lower sales and earnings. Investors are weighing what these updated figures mean for the stock. See our latest analysis for ARYZTA. ARYZTA's recent half year 2026 update comes after a tougher stretch for the stock, with the share price at CHF45.25 and the 30 day share price return down 18.32%. The 1 year total shareholder return is down 39.22%, which points to fading momentum as investors...
SWX:ADEN
SWX:ADENProfessional Services

Adecco Group (SWX:ADEN) Wins 2026 HR Tech Award For AI Career Platform

Adecco Group (SWX:ADEN) unit LHH Career Studio has received the Career Development Innovation Award at the 2026 HR Tech Breakthrough Awards. The award recognizes LHH Career Studio's AI powered career transition platform for its role in digital talent solutions. The recognition comes as Adecco Group continues to focus on AI and digital transformation across its services. Readers looking for more ideas in AI focused talent and HR technology can explore 130 AI small caps. SWX:ADEN Earnings &...
SWX:SQN
SWX:SQNCapital Markets

Swissquote (SWX:SQN) Stock Price Slides As Margin Strength Meets Growth Doubts

Swissquote Group Holding heads into the post earnings session with a stock that has drifted lower in recent weeks, despite a profit story that still looks powerful. The market has marked the share price down over the past month, yet trailing net income and earnings per share point to a business that continues to convert revenue into profit at a high level. The heart of this release is margin resilience. A trailing net profit margin above 40% indicates that Swissquote is still keeping a very...
SWX:NESN
SWX:NESNFood

Nestlé (SWX:NESN) Climbed, So What Is Driving Attention Now?

Nestlé stock in focus after renewed growth narrative Nestlé (SWX:NESN) is back on investors’ radar after recent coverage highlighted its profitability trends and focus on health science nutrition, pet care, premium coffee and related protein segments linked to growing whey protein demand. See our latest analysis for Nestlé. Nestlé’s share price has climbed 6.06% year to date to CHF81.07, while a 17.08% total shareholder return over the past year suggests that investors are gradually warming...
SWX:AMS
SWX:AMSSemiconductor

ams-OSRAM (SWX:AMS) Shares Jumped, What Is Behind The Move?

ams-OSRAM (SWX:AMS) shares are in focus after the company reported Q2 2026 results showing higher sales but a larger net loss, alongside fresh Q3 guidance and a softer full year revenue outlook. See our latest analysis for ams-OSRAM. The Q2 update and new Q3 guidance follow a strong rebound in ams-OSRAM's share price, with a year-to-date share price return of 122.75% and a 1-year total shareholder return of 81.21%, although the 5-year total shareholder return is down 79.53%. If this earnings...
SWX:ALC
SWX:ALCMedical Equipment

3 European Stocks Estimated To Be Up To 49.8% Below Intrinsic Value

The European stock market has recently shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.70% amid firmer risk appetite and robust earnings, despite a volatile geopolitical environment. As investors navigate these conditions, identifying undervalued stocks becomes crucial for capitalizing on potential opportunities within this fluctuating landscape.
SWX:ALC
SWX:ALCMedical Equipment

Alcon (SWX:ALC) Stock Grapples With Profit Reset Despite Stronger Sales

Alcon stock closed at CHF61.06 on 11 August after a strong run over the past quarter. Yet the real story now sits in the income statement. Q2 sales landed at about US$2.8b with 7% growth, but the headline tension for investors is profits. Trailing 12 month net profit margin is 5.9% compared with 10.7% a year earlier, held back by a US$453m one off loss that still hangs over reported earnings. For anyone thinking beyond this quarter, the key question is how quickly those margins can rebuild as...
SWX:TECN
SWX:TECNLife Sciences

Tecan Group (SWX:TECN) Stock Faces Margin Squeeze Despite Rewired Progress

Tecan Group stock closed at CHF181.2 on the day of its half year 2026 report, after a choppy few months that left the shares down over the past week but still well ahead over ninety days. The headline is not the top line. The real story is a margin picture under pressure, with gross margin slipping while adjusted EBITDA margin held at 15.1% and cash generation came in soft at CHF17m. Short term traders are reacting to squeezed profitability. Long term holders now have to judge whether the...
SWX:ADEN
SWX:ADENProfessional Services

Adecco Group (SWX:ADEN) Reported Higher Sales And Lower Net Income, Is It Above Fair Value?

Adecco Group (SWX:ADEN) is in focus after reporting half year 2026 results that showed slightly higher sales but a small decline in net income, raising fresh questions about earnings quality and stock valuation. See our latest analysis for Adecco Group. Adecco Group's latest earnings update arrives after a strong run in the share price. The 30 day share price return is 35.98% and the 90 day share price return is 54.89%. However, the 1 year total shareholder return is still down 5.37%, which...
SWX:ARYN
SWX:ARYNFood

ARYZTA (SWX:ARYN) Stock Faces Debt Questions After Flat First Half

ARYZTA stock came into today on the back foot, with the share price down about 18% over the past three months. However, the latest earnings headline is less about the income statement and more about the balance sheet. The company still carries a high level of debt, which now sits against a business generating trailing net income of just over €100m and a net margin under 5%. For you as an investor, the key question after this set of numbers is simple: does the current P/E discount and heavy...
SWX:LOGN
SWX:LOGNTech

Should Logitech’s Q1 Beat, Buybacks and Streamlabs Upgrade Require Action From Logitech (SWX:LOGN) Investors?

In late July 2026, Logitech International reported first-quarter sales of US$1,227.23 million and net income of US$235.7 million, while issuing second-quarter fiscal 2027 sales guidance of US$1,185 million to US$1,220 million and completing a US$100.78 million buyback of 926,000 shares. Logitech’s Streamlabs unit also introduced Network Boost for Streamlabs Ultra, turning everyday smartphones into bonded Wi‑Fi and cellular links to improve mobile stream reliability and expand higher-margin...
SWX:CICN
SWX:CICNElectronic

European Value Stocks Estimated Below Intrinsic Worth In August 2026

European markets have recently shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.70%, supported by firm risk appetite and stable earnings despite ongoing geopolitical volatility. As investors navigate these conditions, identifying stocks that are potentially undervalued compared to their intrinsic worth can offer opportunities for those looking to capitalize on market inefficiencies.
SWX:CLN
SWX:CLNChemicals

Clariant (SWX:CLN) Lifts Profitability, Is The Upside Already Priced In?

Clariant (SWX:CLN) has drawn fresh attention after reporting half year 2026 earnings that combined lower sales with higher profitability, including stronger net income and earnings per share from continuing operations. See our latest analysis for Clariant. The latest half year earnings and the favorable court ruling at the end of July appear to have supported sentiment around Clariant, with the CHF10.10 share price reflecting a 35.39% 1 month share price return and a 41.95% year to date share...